Anne Peters is a endocrinologist, diabetes expert, and professor of clinical medicine at the Keck School of Medicine of USC. She runs diabetes centers in well-served Beverly Hills and under-resourced East Los Angeles. She teaches physicians and people with diabetes around the world how to better treat the condition, through lifestyle, medications and technology.

Anne L. Peters
Born
NationalityAmerican
Alma materWesleyan University
Pritzker School of Medicine at the University of Chicago
OccupationDiabetologist
SpouseEric Roth
Children1

Early life and education

edit

Peters was born in New York City, New York, but spent much of her youth in Madison, Wisconsin. She attended Wesleyan University (B.A. in biology, 1979),[1] and earned an M.D. from the Pritzker School of Medicine in 1983.[2] She did her residency in Internal Medical at Stanford University Medical Center and Harbor–UCLA Medical Center and her fellowship in endocrinology at Cedars-Sinai Medical Center.[3] During her senior year of medical school she worked at Elim Hospital in Gazankulu, South Africa.

Career

edit

Peters ran diabetes programs at Cedars, then at UCLA and finally moved to USC so she could spend more time working with the underserved. Currently she holds the rank of Professor of Clinical Medicine, Clinical Scholar, the highest clinical rank in the Keck School of Medicine of USC. She has written many articles, four books and has received many research grants. For the past 20 years she has worked with the Department of Health Services for Los Angeles County developing a county-wide system for diabetes care.[4][5][6][7][8]

Peters has been part of multiple guideline writing groups and has written national and international guidelines. These include guidelines for transitioning care,[9] the management of type 1[10] and type 2 diabetes[11][12] and use of diabetes devices.[13][14][15][16][17] She was a member of the ADA Professional Practice Committee writing the 2020, 2021 and 2022 ADA Standards of Care.[18][19][20] She, along with several colleagues, was the first to publish a large case series about the risk of a severe condition known as diabetic ketoacidosis in people taking a type of medication known as an SGLT-2 inhibitor.[21][22]

Her work in East LA was featured in the PBS series Remaking American Medicine.[23] She received the American Diabetes Association "Outstanding Physician Clinician" Award in 2008,[24] the Bernardo Alberto Houssay Award from the National Minority Quality Forum in 2010 and the Endocrine Society Laureate Award for Outstanding Public Service in 2021.[3][25] Multiple patients have noted her involvement in their lives—Don Rickles wrote of her in his book Rickles' Letters[26] and William Friedkin did so in The Friedkin Connection.[27] Larry King featured her on a segment of Larry King Live. She worked with Olympian Gary Hall Jr[28] and Indy car driver Charlie Kimball.

She is a Fellow of the American College of Physicians.[3]

#MeToo

edit

In 1999, she was allegedly assaulted by a patient in an exam room at UCLA. She wrote an essay about the experience keeping the name of the patient anonymous.[29] His identity was revealed by a Vanity Fair reporter, identifying him as Les Moonves.[30] Moonves then admitted to trying to force his doctor to "kiss him". Peters' confidential testimony to the CBS lawyers, which was subsequently leaked to the press,[31] helped strip Moonves of his severance package.

References

edit
  1. ^ Faught, Andrew (December 10, 2014). "ANNE PETERS '79 MD: DIABETES SURGE IS HER 'CALL TO ARMS'". Wesleyan University Magazine. Retrieved July 13, 2022.
  2. ^ "Anne L. Peters, MD". Cardiometabolic Health Congress. Retrieved July 13, 2022.
  3. ^ a b c "Keck School Faculty". Keck School of Medicine of USC.
  4. ^ Ruelas, V; Iverson, E; Kiekel, P; Peters, A (2012). "The role of farmers' markets in two low income, urban communities". J Community Health. Vol. 37, no. 3. pp. 554–562. doi:10.1007/s10900-011-9479-y. PMID 21922162.
  5. ^ Huckfeldt, PJ; Meeker, D; Peters, A; Guterman, JJ; Diaz, G Jr; Goldman, DP (2012). "Diabetes management for low-income patients in Los Angeles: two strategies improved disease control in the short term". Health Aff (Millwood). Vol. 31, no. 1. pp. 168–176. doi:10.1377/hlthaff.2011.0930. PMC 3883628. PMID 22232107.
  6. ^ Sequeira, PA; Montoya, L; Ruelas, V; Xing, D; Chen, V; Beck, R; Peters, AL (2013). "Continuous glucose monitoring pilot in low-income type 1 diabetes patients". Diabetes Technol Ther. Vol. 15, no. 10. pp. 855–858. doi:10.1089/dia.2013.0072. PMC 3781124. PMID 23865840.
  7. ^ Hillstrom, Katherine; Ruelas, Valerie; Peters, Anne; Gedebu-Wilson, Turusew; Iverson, Ellen (2014). "A Retrospective Analysis of the Capacity Built through a Community-Based Participatory Research Project Addressing Diabetes and Obesity in South and East Los Angeles". Health, Vol.6 No.12.
  8. ^ Orrange, S; Ruelas, V; Peters, AL (December 7, 2021). "Specialized Technology Education for Pumps and Pens in Underserved Populations with Diabetes". Diabetes Technol Ther. Vol. 24, no. 4. pp. 268–275. doi:10.1089/dia.2021.0265. PMID 34809482.
  9. ^ Peters, A; Laffel, L (2011). "American Diabetes Association Transitions Working Group. Diabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems: a position statement of the American Diabetes Association, with representation by the American College of Osteopathic Family Physicians, the American Academy of Pediatrics, the American Association of Clinical Endocrinologists, the American Osteopathic Association, the Centers for Disease Control and Prevention, Children with Diabetes, The Endocrine Society, the International Society for Pediatric and Adolescent Diabetes, Juvenile Diabetes Research Foundation International, the National Diabetes Education Program, and the Pediatric Endocrine Society (formerly Lawson Wilkins Pediatric Endocrine Society)". Diabetes Care. 34 (11): 2477–2485. doi:10.2337/dc11-1723. PMC 3198284. PMID 22025785.
  10. ^ Holt, RIG; DeVries, JH; et al. (2021). "The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)". Diabetologia. 64 (12): 2609–2652. doi:10.1007/s00125-021-05568-3. PMC 8481000. PMID 34590174.
  11. ^ Inzucchi, SE; Bergenstal, RM; et al. (2012). "Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)". Diabetes Care. 35 (6): 1364–1379. doi:10.2337/dc12-0413. PMC 3357214. PMID 22517736.
  12. ^ Inzucchi, SE; Bergenstal, RM; et al. (2015). "Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes". Diabetes Care. 38 (1): 140–149. doi:10.2337/dc14-2441. PMID 25538310. S2CID 16704514.
  13. ^ Heinemann, L; Fleming, GA; Petrie, JR; Holl, RW; Peters, AL (2015). "Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group". Diabetes Care.
  14. ^ Peters, AL; Ahmann, AJ; et al. (2016). "Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline". J Clin Endocrinol Metab.
  15. ^ Petrie, JR; Peters, AL; Bergenstal, RM; Holl, RW; Fleming, GA; Heinemann, L (2017). "Improving the clinical value and utility of CGM systems: issues and recommendations : A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group". Diabetologia. doi:10.1007/s00125-017-4463-4.
  16. ^ Peters, AL; Ahmann, AJ; Hirsch, IB; Raymond, JK (October 5, 2018). "Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines". Journals of the Endocrine Society.
  17. ^ Fleming, GA; Petrie, JR; Bergenstal, RM; Holl, RW; Peters, AL; Heinemann, L (2020). "Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group". Diabetes Care.
  18. ^ "Professional Practice Committee: Standards of Medical Care in Diabetes—2020". Diabetes Care. December 16, 2019.
  19. ^ "Professional Practice Committee: Standards of Medical Care in Diabetes—2021". Diabetes Care. December 4, 2020.
  20. ^ "Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2022". Diabetes Care. December 16, 2021.
  21. ^ Peters, AL; Buschur, EO; Buse, JB; Cohan, P; Diner, JC; Hirsch, IB (2015). "Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition". Diabetes Care.
  22. ^ Peters, AL; Henry, RR; Thakkar, P; Tong, C; Alba, M (2016). "Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes". Diabetes Care.
  23. ^ "The Stealth Epidemic". Remaking American Medicine. October 5, 2006. PBS. Archived from the original on January 12, 2020. Retrieved January 10, 2022.
  24. ^ "1975 - 2021 Outstanding Physician-Clinician Award". ADA.
  25. ^ "2021 Laureate Award Recipients". Endocrine Society.
  26. ^ Rickles, Don; Ritz, David (2008). Rickles' Letters. Simon & Schuster.
  27. ^ Friedkin, William (2013). The Friedkin Connection. HarperCollins.
  28. ^ "Cases: Diabetic´s Olympian Triumph". The New York Times. October 31, 2000.
  29. ^ Peters, AL (2018). "A Physician's Place in the #MeToo Movement". Ann Intern Med. Vol. 168, no. 9. pp. 676–677. doi:10.7326/M18-0271.
  30. ^ Cohan, William D. (September 9, 2018). "LES MOONVES ADMITS TO UNWANTED KISSING OF HIS DOCTOR 19 YEARS AGO". Vanity Fair.
  31. ^ Stewart, James B. (December 4, 2018). "'Disaster for CBS Shareholders': Damning Report on Moonves Reveals Total Failure at Top". The New York Times.